195 related articles for article (PubMed ID: 24986387)
1. Anti-basal ganglia antibodies in primary obsessive-compulsive disorder: systematic review and meta-analysis.
Pearlman DM; Vora HS; Marquis BG; Najjar S; Dudley LA
Br J Psychiatry; 2014 Jul; 205(1):8-16. PubMed ID: 24986387
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study.
Nicholson TR; Ferdinando S; Krishnaiah RB; Anhoury S; Lennox BR; Mataix-Cols D; Cleare A; Veale DM; Drummond LM; Fineberg NA; Church AJ; Giovannoni G; Heyman I
Br J Psychiatry; 2012 May; 200(5):381-6. PubMed ID: 22282431
[TBL] [Abstract][Full Text] [Related]
3. [Anti-basal ganglia antibody].
Hayashi M
Brain Nerve; 2013 Apr; 65(4):377-84. PubMed ID: 23568985
[TBL] [Abstract][Full Text] [Related]
4. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder.
Dale RC; Heyman I; Giovannoni G; Church AW
Br J Psychiatry; 2005 Oct; 187():314-9. PubMed ID: 16199788
[TBL] [Abstract][Full Text] [Related]
5. Anti-Basal Ganglia Antibodies and Streptococcal Infection in ADHD.
Aguilera-Albesa S; Crespo-Eguílaz N; Del Pozo JL; Villoslada P; Sánchez-Carpintero R
J Atten Disord; 2018 Jul; 22(9):864-871. PubMed ID: 25882837
[TBL] [Abstract][Full Text] [Related]
6. Anti-brain antibodies in adult patients with obsessive-compulsive disorder.
Maina G; Albert U; Bogetto F; Borghese C; Berro AC; Mutani R; Rossi F; Vigliani MC
J Affect Disord; 2009 Aug; 116(3):192-200. PubMed ID: 19138800
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder.
Sanchez-Carpintero R; Albesa SA; Crespo N; Villoslada P; Narbona J
J Neurol; 2009 Jul; 256(7):1103-8. PubMed ID: 19288046
[TBL] [Abstract][Full Text] [Related]
8. Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder.
Bhattacharyya S; Khanna S; Chakrabarty K; Mahadevan A; Christopher R; Shankar SK
Neuropsychopharmacology; 2009 Nov; 34(12):2489-96. PubMed ID: 19675532
[TBL] [Abstract][Full Text] [Related]
9. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.
Church AJ; Dale RC; Lees AJ; Giovannoni G; Robertson MM
J Neurol Neurosurg Psychiatry; 2003 May; 74(5):602-7. PubMed ID: 12700302
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid findings in patients with obsessive-compulsive disorder, Tourette syndrome, and PANDAS: A systematic literature review.
Pankratz B; Feige B; Runge K; Bechter K; Schiele MA; Domschke K; Prüss H; Tebartz van Elst L; Nickel K; Endres D
Brain Behav Immun; 2024 Jan; 115():319-332. PubMed ID: 37748568
[TBL] [Abstract][Full Text] [Related]
11. Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy.
Giedd JN; Rapoport JL; Leonard HL; Richter D; Swedo SE
J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):913-5. PubMed ID: 8768351
[TBL] [Abstract][Full Text] [Related]
12. Tic disorders and obsessive-compulsive disorder: is autoimmunity involved?
Hoekstra PJ; Minderaa RB
Int Rev Psychiatry; 2005 Dec; 17(6):497-502. PubMed ID: 16401548
[TBL] [Abstract][Full Text] [Related]
13. Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome.
Morer A; Lázaro L; Sabater L; Massana J; Castro J; Graus F
J Psychiatr Res; 2008 Jan; 42(1):64-8. PubMed ID: 17113107
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: A retrospective analysis of 54 samples.
Pankratz B; von Zedtwitz K; Runge K; Denzel D; Nickel K; Schlump A; Pitsch K; Maier S; Dersch R; Voderholzer U; Domschke K; Tebartz van Elst L; Schiele MA; Prüss H; Endres D
World J Biol Psychiatry; 2023 Apr; 24(4):292-302. PubMed ID: 35904379
[TBL] [Abstract][Full Text] [Related]
15. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea.
Church AJ; Cardoso F; Dale RC; Lees AJ; Thompson EJ; Giovannoni G
Neurology; 2002 Jul; 59(2):227-31. PubMed ID: 12136062
[TBL] [Abstract][Full Text] [Related]
16. Antineuronal antibodies: tics and obsessive-compulsive symptoms.
Kiessling LS; Marcotte AC; Culpepper L
J Dev Behav Pediatr; 1994 Dec; 15(6):421-5. PubMed ID: 7884013
[TBL] [Abstract][Full Text] [Related]
17. Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype?
Endres D; Pollak TA; Bechter K; Denzel D; Pitsch K; Nickel K; Runge K; Pankratz B; Klatzmann D; Tamouza R; Mallet L; Leboyer M; Prüss H; Voderholzer U; Cunningham JL; ; Domschke K; Tebartz van Elst L; Schiele MA
Transl Psychiatry; 2022 Jan; 12(1):5. PubMed ID: 35013105
[TBL] [Abstract][Full Text] [Related]
18. PANDAS: current status and directions for research.
Snider LA; Swedo SE
Mol Psychiatry; 2004 Oct; 9(10):900-7. PubMed ID: 15241433
[TBL] [Abstract][Full Text] [Related]
19. Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function?
Murphy TK; Petitto JM; Voeller KK; Goodman WK
Semin Clin Neuropsychiatry; 2001 Oct; 6(4):266-76. PubMed ID: 11607922
[TBL] [Abstract][Full Text] [Related]
20. Serologic survey of adult patients with obsessive-compulsive disorder for neuron-specific and other autoantibodies.
Black JL; Lamke GT; Walikonis JE
Psychiatry Res; 1998 Dec; 81(3):371-80. PubMed ID: 9925188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
